Now with over 4,500 members from all over the world, EASL is an influential international organisation. It attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education, and promoting changes in European liver policy.
Leadership & Governance
Ethics Committee
The role of the Ethics Committee will be to review the membership of the panels which author EASL’s Clinical Practice Guidelines to eliminate the potential for real or perceived bias which might undermine the integrity of the guidelines. The Ethics Committee will agree on guidelines for reviewing appointments to the Clinical Practice Guideline panels. Candidate membership of the panels will be proposed by the Governing Board for approval by the Ethics Committee according to these guidelines.
The Ethics Committee consists of five members who will be independent of the Governing Board membership. One member, elected by the Ethics Committee, will perform the role of the chair. Members will serve for three years. The first members of the Ethics Committee will be proposed by the Governing Board for approval by the General Assembly. New members will be proposed by the Ethics Committee for approval by the General Assembly. The Ethics Committee will meet once each year at the International Liver Congress™ and as needed.
Prof. Geoffrey M. Dusheiko
EASL Ethics Committee ChairpersonUK
Prof. Jaime Bosch
EASL Ethics Committee MemberSpain
Prof. Markus Heim
EASL Ethics Committee MemberSwitzerland
Prof. Ariane Mallat
EASL Ethics Committee MemberFrance
Prof. Christian Trautwein
EASL Ethics Committee MemberGermany